secwatch.observer — SEC 8-K summary
======================================

Issuer:     STRATA Skin Sciences, Inc. (SSKN)
CIK:        0001051514
Form:       8-K
Filed at:   2023-07-11T23:59:59+00:00
Accession:  0001140361-23-034075
Event type: other_material
Sentiment:  positive
Materiality: 0.35
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Strata Skin Sciences announces JCAD publication highlighting TheraClearX for acne treatment
--------------------------------------------------------------------------------

- Journal of Clinical and Aesthetic Dermatology published review and expert article on TheraClearX for mild-to-moderate acne vulgaris.
- Article highlights visible improvement as early as second treatment, no downtime, and customization for all Fitzpatrick skin types.
- CEO Bob Moccia stated the publication expands on device's safety, efficacy, and integration into practice.
- Dr. Gilly Munavalli, author, noted TheraClearX is effective non-pharmaceutical acne treatment with little downtime.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1051514/000114036123034075/0001140361-23-034075-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1051514/000114036123034075/brhc20055766_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-23-034075

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer